Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech has filed a compliance statement under SEBI Listing Regulations confirming that the company has no unutilized funds as of 31st March 2025 from any past public issue, rights issue, preferential issue, or qualified institutional placement (QIP). Because there are no unutilized proceeds, the company has not submitted the standard Annexure-A form that tracks fund usage and deviations. The filing has been made with BSE, Calcutta Stock Exchange, and Metropolitan Stock Exchange of India.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company has fully utilized any past issue proceeds and has nothing to report on fund usage deviations.